Purple Biotech (PPBT) Institutional Ownership $3.17 -0.08 (-2.46%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$3.14 -0.02 (-0.79%) As of 02/21/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Purple Biotech (NASDAQ:PPBT)CurrentInstitutional OwnershipPercentage9.64%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$229.66KNumber ofInstitutional Sellers(last 12 months)1 Get PPBT Insider Trade Alerts Want to know when executives and insiders are buying or selling Purple Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PPBT Institutional Buying and Selling by Quarter Purple Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 Two Sigma Securities LLC15,374$72K0.0%N/A1.156% 1/22/2025 Kingswood Wealth Advisors LLC33,594$158K0.0%N/A2.526% 8/15/2024 Armistice Capital LLC1,358,000$553K0.0%-35.8%5.381% 2/13/2024 Armistice Capital LLC1,882,173$1.47M0.0%N/A8.544% 2/6/2024WuXi AppTec Co. Ltd.194,139$151K0.4%N/A0.881% 1/16/2024 Kingswood Wealth Advisors LLC175,100$137K0.0%+34.0%0.795% 8/9/2023 Kingswood Wealth Advisors LLC127,950$178K0.1%N/A0.692% 2/3/2023 Fisher Asset Management LLC32,200$44K0.0%N/A0.183% 1/28/2022 ARK Investment Management LLC662,499$2.58M0.0%-10.0%2.554% 11/15/2021 Point72 Asset Management L.P.279,294$1.28M0.0%-46.8%1.077% 10/20/2021 Venture Visionary Partners LLC10,068$46K0.0%N/A0.039% 8/16/2021 Point72 Asset Management L.P.525,000$2.56M0.0%N/A2.024% 8/16/2021 Morgan Stanley37,988$185K0.0%-77.4%0.146% 8/11/2021 Condor Capital Management21,000$102K0.0%N/A0.081% 5/18/2021 Morgan Stanley167,804$693K0.0%-66.1%0.958% 5/18/2021 Orbimed Advisors LLC31,418$130K0.0%-90.9%0.179% 5/13/2021 Renaissance Technologies LLC219,035$905K0.0%+69.9%1.251% 3/26/2021 Susquehanna International Group LLP20,679$79K0.0%N/A0.132% 2/24/2021 Virtu Financial LLC22,988$88K0.0%N/A0.146% 2/16/2021 Orbimed Advisors LLC346,197$1.32M0.0%N/A2.202% 2/10/2021 Renaissance Technologies LLC128,900$491K0.0%N/A0.820% (Data available from 1/1/2016 forward) PPBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PPBT shares? During the previous two years, the following institutional investors and hedge funds held shares of Purple Biotech shares: Armistice Capital LLC ($553K), Kingswood Wealth Advisors LLC ($158K), and WuXi AppTec Co. Ltd. ($151K), Two Sigma Securities LLC ($72K).Learn more on PPBT's institutional investors. What percentage of Purple Biotech stock is owned by institutional investors? 9.64% of Purple Biotech stock is owned by institutional investors. Learn more on PPBT's institutional investor holdings. Which institutional investors have been buying Purple Biotech stock? The following institutional investors have purchased Purple Biotech stock in the last 24 months: Armistice Capital LLC ($1.88M), Kingswood Wealth Advisors LLC ($205.99K), WuXi AppTec Co. Ltd. ($194.14K), and Two Sigma Securities LLC ($15.37K). How much institutional buying is happening at Purple Biotech? Institutional investors have bought a total of 2,297,680 shares in the last 24 months. This purchase volume represents approximately $229.66K in transactions. Which Purple Biotech major shareholders have been selling company stock? The following institutional investors have sold Purple Biotech stock in the last 24 months: Armistice Capital LLC ($757K). How much institutional selling is happening at Purple Biotech? Institutional investors have sold a total of 757,000 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies Spruce Biosciences Institutional Ownership HCW Biologics Institutional Ownership Synlogic Institutional Ownership NeuroSense Therapeutics Institutional Ownership Eagle Pharmaceuticals Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership GeoVax Labs Institutional Ownership Minerva Neurosciences Institutional Ownership Cellectar Biosciences Institutional Ownership Mainz Biomed Institutional Ownership This page (NASDAQ:PPBT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
